LYKA LABS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 118.8 INR | -2.82% |
|
-3.57% | -4.04% |
Valuation
| Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,280 | 676.8 | 358.6 | 748.8 | 3,885 | 2,994 |
| Enterprise Value (EV) 1 | 2,386 | 1,602 | 1,693 | 2,306 | 5,009 | 3,625 |
| P/E ratio | -6.78 x | -11.8 x | -0.59 x | -6.42 x | 9.99 x | -22.5 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 2.23 x | 0.94 x | 0.63 x | 1.09 x | 2.11 x | 3.35 x |
| EV / Revenue | 4.15 x | 2.24 x | 2.99 x | 3.37 x | 2.72 x | 4.05 x |
| EV / EBITDA | -63.3 x | -158 x | -37.2 x | 12.7 x | 5.16 x | 24.4 x |
| EV / FCF | -18.8 x | 8.7 x | -7.88 x | -22.1 x | 16.6 x | -62.6 x |
| FCF Yield | -5.32% | 11.5% | -12.7% | -4.53% | 6.04% | -1.6% |
| Price to Book | 2.42 x | 1.51 x | -2.5 x | -2.9 x | 29.1 x | 7.05 x |
| Nbr of stocks (in thousands) | 28,140 | 28,140 | 28,690 | 28,690 | 28,690 | 28,690 |
| Reference price 2 | 45.50 | 24.05 | 12.50 | 26.10 | 135.4 | 104.4 |
| Announcement Date | 8/13/18 | 8/28/19 | 9/3/20 | 7/8/21 | 7/11/22 | 7/10/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 574.4 | 716.8 | 566.3 | 685.1 | 1,845 | 894.2 |
| EBITDA 1 | -37.66 | -10.14 | -45.57 | 181.4 | 971.4 | 148.8 |
| EBIT 1 | -143.7 | -76.44 | -106.3 | 114.2 | 838.2 | 27.53 |
| Operating Margin | -25.02% | -10.66% | -18.76% | 16.67% | 45.44% | 3.08% |
| Earnings before Tax (EBT) 1 | -200.4 | -154.2 | -618.8 | -141.4 | 592.5 | -131.7 |
| Net income 1 | -172.7 | -55.5 | -605.4 | -115.5 | 390 | -132.1 |
| Net margin | -30.07% | -7.74% | -106.9% | -16.87% | 21.14% | -14.78% |
| EPS 2 | -6.710 | -2.031 | -21.29 | -4.065 | 13.56 | -4.628 |
| Free Cash Flow 1 | -126.9 | 184.2 | -214.9 | -104.5 | 302.3 | -57.87 |
| FCF margin | -22.08% | 25.7% | -37.95% | -15.26% | 16.39% | -6.47% |
| FCF Conversion (EBITDA) | - | - | - | - | 31.12% | - |
| FCF Conversion (Net income) | - | - | - | - | 77.52% | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/13/18 | 8/28/19 | 9/3/20 | 7/8/21 | 7/11/22 | 7/10/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1,105 | 925 | 1,335 | 1,557 | 1,124 | 632 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -29.35 x | -91.24 x | -29.28 x | 8.583 x | 1.157 x | 4.245 x |
| Free Cash Flow 1 | -127 | 184 | -215 | -105 | 302 | -57.9 |
| ROE (net income / shareholders' equity) | -36.9% | -12.9% | -409% | 50.2% | -663% | -44.5% |
| ROA (Net income/ Total Assets) | -3.69% | -2.14% | -3.2% | 3.66% | 27.9% | 1.02% |
| Assets 1 | 4,682 | 2,594 | 18,947 | -3,158 | 1,398 | -12,945 |
| Book Value Per Share 2 | 18.80 | 15.90 | -5.000 | -8.990 | 4.650 | 14.80 |
| Cash Flow per Share 2 | 0.8600 | 0.5600 | 3.460 | 2.490 | 5.940 | 3.820 |
| Capex 1 | 36.1 | 48.2 | 11 | 12.7 | 75.1 | 81.9 |
| Capex / Sales | 6.29% | 6.72% | 1.94% | 1.85% | 4.07% | 9.15% |
| Announcement Date | 8/13/18 | 8/28/19 | 9/3/20 | 7/8/21 | 7/11/22 | 7/10/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -4.04% | 47.12M | |
| +26.08% | 662B | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B |
- Stock Market
- Equities
- LYKALABS Stock
- Financials Lyka Labs Limited
